Atlas Trials

Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma

Clinical trial NCT00772811 · COMPLETED

Trial details

NCT number
NCT00772811
Sponsor
Cooperative Study Group A for Hematology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaLymphomaMultiple Myeloma
Start date
2001-07-01
Primary completion
2010-09-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.